Patents by Inventor Emile Loria

Emile Loria has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DISEASES MODULATED BY A H4 RECEPTOR AGONIST
    Publication number: 20130059878
    Abstract: The invention provides a method for the treatment of H4R modulated diseases and/or conditions comprising administering to the subject an effective amount of a H4R agonist. The invention also provides a method for treating COPD comprising administering to the subject an effective amount of a H4R agonist, a H1R antagonist and an anticholinergic drug. Further, the invention provides a pharmaceutical formulation comprising a H4R agonist, a second active agent and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: May 18, 2012
    Publication date: March 7, 2013
    Inventors: Emile Loria, Michalis Nicolaou, Gaetan Terrasse, Yves Trehin
  • TREATMENT OF COPD, GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD), FOOD ALLERGIES AND OTHER GASTROINTESTINAL CONDITIONS AND DISORDERS AMELIORATED BY PROPER HISTAMINE MANAGEMENT USING A COMBINATION OF HISTIDINE DECARBOXYLASE INHIBATORS, LRA DRUGS, ANTI-H1 AND/OR ANTI-H2 DRUGS
    Publication number: 20120295933
    Abstract: The invention provides a method for the treatment of COPD and/or gastrointestinal disease conditions ameliorated by histamine management in a subject, comprising administering to the subject an effective amount of a histidine decarboxylase inhibitor.
    Type: Application
    Filed: May 18, 2012
    Publication date: November 22, 2012
    Inventors: Emile Loria, Michalis Nicolaou, Gaetan Terrasse, Yves Trehin
  • Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
    Patent number: 8207292
    Abstract: The invention provides a method for the treatment of COPD and/or gastrointestinal disease conditions ameliorated by histamine management in a subject, comprising administering to the subject an effective amount of a histidine decarboxylase inhibitor.
    Type: Grant
    Filed: February 12, 2008
    Date of Patent: June 26, 2012
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • Treatment of diseases modulated by a H4 receptor agonist
    Patent number: 8207188
    Abstract: The invention provides a method for the treatment of H4R modulated diseases and/or conditions comprising administering to the subject an effective amount of a H4R agonist. The invention also provides a method for treating COPD comprising administering to the subject an effective amount of a H4R agonist, a H1R antagonist and an anticholinergic drug. Further, the invention provides a pharmaceutical formulation comprising a H4R agonist, a second active agent and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: June 17, 2009
    Date of Patent: June 26, 2012
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • PURE ISOMERS OF TRITOQUALINE
    Publication number: 20120101120
    Abstract: The invention provides an isolated stereoisomer of tritoqualine having the structure of FIG. 2 and FIG. 3.
    Type: Application
    Filed: August 24, 2011
    Publication date: April 26, 2012
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
    Patent number: 7927600
    Abstract: The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen from: (i) one allergen, (ii) one antihistamine compound, and (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: April 19, 2011
    Inventors: Emile Loria, Gaetan Terrasse, Yves Trehin
  • TREATMENT OF DISEASES MODULATED BY A H4 RECEPTOR AGONIST
    Publication number: 20100144718
    Abstract: The invention provides a method for the treatment of H4R modulated diseases and/or conditions comprising administering to the subject an effective amount of a H4R agonist. The invention also provides a method for treating COPD comprising administering to the subject an effective amount of a H4R agonist, a H1R antagonist and an anticholinergic drug. Further, the invention provides a pharmaceutical formulation comprising a H4R agonist, a second active agent and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: June 17, 2009
    Publication date: June 10, 2010
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugs
    Publication number: 20080207530
    Abstract: The invention provides a method for the treatment of COPD and/or gastrointestinal disease conditions ameliorated by histamine management in a subject, comprising administering to the subject an effective amount of a histidine decarboxylase inhibitor.
    Type: Application
    Filed: February 12, 2008
    Publication date: August 28, 2008
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • Pure isomers of tritoqualine
    Publication number: 20070238750
    Abstract: The invention provides an isolated stereoisomer of tritoqualine having the structure of FIG. 2 and FIG. 3.
    Type: Application
    Filed: April 9, 2007
    Publication date: October 11, 2007
    Inventors: Michalis Nicolaou, Emile Loria, Gaetan Terrasse, Yves Trehin
  • Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
    Publication number: 20070003580
    Abstract: The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen from: (i) one allergen, (ii) one antihistamine compound, and (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: April 28, 2006
    Publication date: January 4, 2007
    Inventors: Emile Loria, Gaetan Terrasse, Yves Trehin
  • Skin testing kit for diagnosing atopy
    Publication number: 20060167375
    Abstract: The instrument for the allergies' detection is a cutaneous kit which has a main body, with a sharp edge (5) around its circumference at the lower surface (4). At least one cavity (21) or hollow space is coaxial to the body (1) for a multi-point needle (8). The outer circumference of the body is bonded to the inner edge of a flexible ring (16), in turn held by a rigid support (17) at its outer edge. The whole of the lower surface of the kit is shrouded by a blister. The cavity and the surrounding space (14) is filled with at least one allergenic substance. The instrument can contain three bodies with their needle assemblies.
    Type: Application
    Filed: October 8, 2003
    Publication date: July 27, 2006
    Inventors: Gaetan Terrassse, Yves Trehin, Emile Loria
  • Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compound
    Publication number: 20060153882
    Abstract: The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen among: (i) one allergen, (ii) one antihistamine compound, (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: December 5, 2005
    Publication date: July 13, 2006
    Inventors: Emile Loria, Gaetan Terrasse, Yves Trehin
  • Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
    Patent number: 7048928
    Abstract: The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen from among: (i) one allergen, (ii) one antihistamine compound, and (iii) one inhibitor of histamine synthesis. The active agents are associated in the composition with a pharmaceutically acceptable vehicle.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: May 23, 2006
    Assignee: Antialis
    Inventors: Emile Loria, Gaetan Terrasse, Yves Trehin
  • Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
    Publication number: 20030104013
    Abstract: The present invention relates to an anti-allergic pharmaceutical composition containing at least two active agents chosen among: (i) one allergen, (ii) one antihistamine compound, (iii) one inhibitor of histamine synthesis, said active agents being associated in said composition with a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: May 29, 2001
    Publication date: June 5, 2003
    Inventors: Emile Loria, Gaetan Terrasse, Yves Trehin